![](/img/cover-not-exists.png)
A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia
Jarskog, L. Fredrik, Pedersen, Cort A., Johnson, Jacqueline L., Hamer, Robert M., Rau, Shane W., Elliott, Tonya, Penn, David L.Language:
english
Journal:
Schizophrenia Research
DOI:
10.1016/j.schres.2017.01.008
Date:
January, 2017
File:
PDF, 538 KB
english, 2017